Skip to main content

Advertisement

Table 2 Preoperative patient characteristics

From: Impact of patient-prosthesis mismatch on 30-day outcomes in young and middle-aged patients undergoing aortic valve replacement

  Without PPM With PPM p
Age 61 (56–66) 64 (57–68) 0,046
Women 49 (35,5%) 18 (29,5%) 0,41
HT 77 (55,8%) 34 (55,7%) 0,99
DM 22 (15,9%) 15 (25%) 0,13
Hypercholesterolemia 70 (50,7%) 27 (44,3%) 0,4
BSA 1,82 ± 0,2 1,91 ± 0,16 0,002
BMI 28,84 ± 4,29 30,07 ± 4,27 0,086
Peripheral arterial disease 13 (9,4%) 11 (18%) 0,085
CPD 20 (14,5%) 11 (18%) 0,52
Previous stroke 4 (2,9%) 4 (6,6%) 0,22
Previous neurological dysfunction 4 (2,9%) 0 (0%) 0,18
Preoperative creatinine concentration 0,94 (0,8–1,09) 1 (0,86–1,17) 0,043
Previous AF 18 (13%) 7 (11,5%) 0,76
Previous AMI 1 (0,7%) 1 (1,6%) 0,55
LVD 16 (11,6%) 7 (11,5%) 0,98
SPHT 14 (10,1%) 9 (14,8%) 0,35
Peak transaortic pressure gradient 81 (70–91) 81 (71–93) 0,93
Associated aortic regurgitation 27 (19,6%) 16 (26,2%) 0,29
Emergency surgery 4 (2,9%) 1 (1,6%) 0,61
Logistic EuroSCORE 2,8 (2,1–4,6) 2,9 (2,1–5,1) 0,51
Previous pacemaker implantation 0 (0%) 2 (3,3%) 0,033
NYHA functional class III-IV 67 (48,6%) 30 (49,2%) 0,93
Etiology    
Degenerative disease 90 (65,2%) 41 (67,2%) 0,78
Congenital disease 37 (26,8%) 13 (21,3%) 0,41
Rheumatic disease 11 (8%) 7 (11,5%) 0,43
  1. HT: HYPERTENSION; DM: DIABETES MELLITUS; BSA: BODY SURFACE AREA; BMI: BODY MASS INDEX; COPD: CHRONIC PULMONARY DISEASE; AF: ATRIAL FIBRILLATION; AMI; ACUTE MYOCARDIAL INFARCTATION; LVD: LEFT VENTRICULAR DYSFUNCTION; SPHT; SEVERE PULMONAR HYPERTENSION; NYHA: NEW YORK HEART ASSOCIATION.